The Evolution Summit returns May 7-8, 2026 at The Ritz-Carlton, Fort Lauderdale, Florida, bringing together leading clinical trial executives with innovative suppliers and solution providers in an invitation-only, premium setting. Expect visionary keynotes, real-world case studies, and interactive forums aligned to the most pressing challenges in clinical operations and drug development. Featured leaders include…
Shots:
Thermo Fisher has entered into a definitive agreement to acquire Clario, enhancing its digital & data capabilities in clinical research
As per the deal, Thermo Fisher Scientific will acquire Clario for $8.875B in cash, with an additional $125M due in January 2027 & ~$400M in performance-based earnouts for 2026–2027; closing is expected mid-2026, after…
Shots:
Research into Lupus has yielded groundbreaking results in pharmacokinetics and pharmacodynamics, yet experts still don't understand its cause
Lupus Research Alliance (LRA) recently launched a platform called Data Repository, Exchange, and Analytics (DREAM) for data sharing and partnerships for research in lupus
Devon Kelly, Director of Lupus Nexus at the Lupus Research Alliance, sheds…
Shots:
Precision medicine holds a promising foothold in addressing unmet healthcare needs and bridging the gaps in care accessibility and high treatment costsÂ
Defying the one-size-fits-all model, personalized medicine offers therapies tailored to an individual’s physiology, lifestyle, and environmentÂ
With this article, let’s capture the intricacies of precision medicine by navigating the benefits, challenges, progress,…
Shots:
AI is widely used in drug discovery and clinical research to find innovative cures for several debilitating conditions with unmet healthcare needsÂ
Most of the AI architecture employs deep learning that requires extensive training data sets to produce reliable predictive modelsÂ
Today, at PharmaShots, we have Adityo Prakash, CEO of Verseon, addressing the challenges…
Shots:
Marisa Cruz, MD, and Chief Medical Officer at Empatica, exchanged thoughts with PharmaShots on the revolutionary Empatica Health Monitoring Platform (EHMP)Â Â
Approved by the FDA in Nov’2022, EHMP leverages a cloud-based online portal to collect continuous and seamless physiological data from home and clinical setting Â
While conversing in great depth about Empatica’s EmbracePlus smartwatch,…
Shots:
Ahsan spoke about the US FDA acceptance for Priority Review of sBLAs for PADCEV and KEYTRUDA to treat patients with LA/mUC who are not eligible to receive cisplatin-containing CT
He also talked about the study design and outcomes from the P-Ib/II (EV-103) clinical trial that supported the sBLA. The results from Dose Escalation/Cohort A…
Shots:
Martin gave a detailed view of the newly launched Honey Analytics module associated with the Trialbee Honeyâ„¢ platform
He also talked about the how Trialbee Honey platform will help in the screening and recruiting of patients specifically in remote areas
The interview gives a profound understanding of how Trialbee is developing real-time monitoring modules…

